Diana Roth O’Brien, MD MPH
@drothens
Followers
1K
Following
58K
Media
4
Statuses
96
Radiation oncologist @MSKCancerCenter, aspiring puppy hoarder | @princeton 08 ➡️ @sunydownstate MD/MPH ➡️ @weillcornell
Manhattan, NY
Joined December 2009
Hey #radonc! Trainees seeking an up-to-date treatment guide, attendings interested in learning about MSKCC treatment approaches, and leaders looking to standardize practice across your departments: add this text to your collection! 📖☢️ @LiorBraunstein
https://t.co/qFXWYy4Pmz
1
11
47
“Personalized Approaches to Breast Radiotherapy: Strategies for Treatment Refinement” by Diana A. Roth O’Brien, MD, MPH; and Lior Z. Braunstein, MD https://t.co/SWyDlcg9WB
@drothens @LiorBraunstein @MSKCancerCenter
hematologyandoncology.net
Abstract: Radiotherapy (RT) is a crucial component of the adjuvant treatment of breast cancer that often follows breast conservation or mastectomy to further reduce the risk […]
1
1
2
Vegan soul food with these amazing physicians. Thank you to my @MSKCancerCenter colleagues for dinner tonight ...and for your support and friendship over the past 5 years. 🙏🙌❤️ #weekendsinNYC
0
4
41
📢We are overjoyed to announce that Dr @HimanshuNagarMD will be joining @MSKCancerCenter this summer as our Genitourinary Cancer Disease site leader. Dr Nagar is a compassionate clinician & innovative researcher. We are excited to see where he leads our GU #radonc team!
21
20
116
New from @MSKCancerCenter: The optimal tx strategy for anal adenocarcinoma is evolving. This is the 1st report to describe the safety & feasibility of watch & wait in pts who achieved a clinical complete response after neoadjuvant tx for adeno #ancsm
https://t.co/SNFArfHjjU
0
4
10
New in @IJROBP from Dr @drothens @LiorBraunstein & the @MSKCancerCenter #radonc team: Is #APBI an option for favorable risk #Her2+ #breastCancer? This study finds excellent short-term local control for HER2+ #bcsm treated with partial breast #radiation ☢️ https://t.co/IrUlptpJ6J
0
8
32
By 8 weeks after #APBI, most patients reported resolution of symptoms, with 16% reporting residual moderate symptoms. No ascertained salient dosimetric ☢️ parameters were associated with max symptoms or with mod to very severe toxicity. #breastCancer #bcsm
https://t.co/2mKG4uIOkk
0
2
7
🎙PBI ✖️WBI for early-stage #breastcancer: @JNCI_Now 📌Metanalysis:17,234 👥➡️14 RCTs & 6 observational - 🥇endpoints: IBR,cosmetics & AEs 📊Findings: 👉5y IBR: PBI = WBI (RR 1.34, 95% CI 0.83—2.18) 👉10y IBR: PBI = WBI (RR 1.29, 95% CI 0.87—1.91) 👉Cosmesis:Insufficient
1
26
45
🔥🔥🔥 Brilliant take on the PROSPECT Trial 🔑🔑🔑 Points 🔑Patient selection (ie. Trial included favorable risk factors with exclusion of T4, N2, distal tumors not amenable to LAR, or within 3 mm of MRF) 🔑 Treatment intent (operative vs. watch & wait) #ASCO23 👇🏼👇🏼👇🏼
Congrats to the authors of the PROSPECT trial! A tremendous accomplishment. #ASCO23 Some thoughts:
0
10
30
Listen to Dr. @LiorBraunstein of @MSKCancerCenter, the principal investigator for the @NRGonc “HERO” study, explain why he is excited for this potentially paradigm-shifting trial in HER-2 positive #breastcancer. #bcdm
https://t.co/o5mfwskYBD
nrgoncology.org
NRG-BR008, the "HERO" study, was featured as a new trial in our March NRG Currents edition. Learn more about the phase 3 randomized study seeking to optimize use of #radiotherapy in patients with early-stage low-risk, HER2-positive #breastcancer - https://t.co/Ail3e11qZO
0
1
6
It's a Match! Welcome to @MSKCancerCenter #radonc!! 🥳 🙌Kathryn Hockemeyer MD, PhD 🙌Gideon Haber, MD 🙌Elisa Liu, MD 🙌Revathi Ravella, MD 🙌Alexander Terry, MD 🙌Shoshana Rosenzweig, MD We're excited to have you join us in New York! #Match2023 #radoncMatch2023
1
14
126
🚨New in #AdvancesRO from @MSKCancerCenter #radonc: A tattoo-less setup with surface imaging (AlignRT) appears to be just as accurate for radiation alignment for #breastCancer #PBI --tattoos may not be necessary for #bcsm in the future. @LiorBraunstein
https://t.co/GtuDui21Ij
1
7
17
🚨#OncTwitter #HCWvsHunger RED ALERT🚨 🧪#Feedalizumab @tmprowell ☢️#RadiatePositivity 🩸#BadBlood @MaryCushmanMD HAVE MERGED TO FORM SUPER GROUP #HemOnculus 💪🧬⚡️ 🚨WE ARE WITHIN STRICKING DISTANCE OF #1. Let's GOOOOOOOOO!!!!
7
4
16
Did you know @MSKCancerCenter Dr @fumikochino is organizing the team #RadiatePositivity for the annual #HCWvsHunger competition? This year @HCWvsHunger has raised >$450k for food banks to combat #foodinsecurity over the holidays and the #radonc team specifically has raised >$22k!
2
5
15
Inspired by @DrEmmaHolliday re: GI ASTRO recap, I gave a talk on high-yield BrCa abstracts from #ASTRO22. Too many great studies to include, but here are some highlights. Let me know your thoughts! And what did I miss? @IBCradiation @ChelainG @SFShaitelmanMD @PSchlembachMD 1/6
2
18
78
NRG/RTOG 1005 - concurrent versus sequential boost #ASTRO22 for breast #radiotherapy. Concurrent boost is non-inferior. No difference in QoL. Concordance with IMPORT High results. This patient-centric trial will save time for patients with #breastcancer. #bcsm #oncoalert
0
75
173
Work life balance is alternating which I’m failing at on any given day.
28
54
673
Lovely brunch with @MSKCancerCenter #radonc colleagues. Topics on deck: what successful leadership looks like, establishing an effective collaborative team, why executive coaching matters, and (of course) trampoline fitness. On multiple “to do” lists: book #astro22 hotels!
1
4
51
A glimmer of good amidst the doom. Finally (1/2) vaccinated and couldn’t be more joyous. @ Bergen New Bridge Medical Center
0
0
1
MSK’s Ralph Lauren Center in the heart of Harlem provides cancer prevention, diagnosis, treatment, and support services for the local community. For patients like Maria, having a care team that feels like family can make all the difference. https://t.co/B3qZB8LpT3
mskcc.org
See how experts at Memorial Sloan Kettering Cancer Center's Ralph Lauren Center cared for Maria close to home.
0
3
9